Lindhe Ö, Skogseid B and Brandt I (2002) Cytochrome P450-catalyzed binding of 3- methylsulfonyl-DDE and o,p'-DDD in human adrenal zona fasciculata/reticularis. J Clin Endocrinol Metab. 87: 1319-1326.
Hermansson V, Cantillana T, Hovander L, Bergman A, Ljungvall K, Magnusson U, Törneke K, Brandt I (2008). Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (Mitotane) in Minipigs. Cancer Chemother Pharmacol., 61(2):267-74.
Hermansson V, Asp V, Bergman Å, Bergström U, Brandt I (2007). Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p’-DDD in Y-1 adrenal cells. Arch Toxicol, 81, 793-801.
Allolio B, Fassnacht M (2006). Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab. 91:2027-2037
Hartmann R W, Voets M, Műller-Vieira U (2006) Selective inhibitors of human corticosteroid synthases. WO 2006/092430Kanske